Welcome to OCRA’s Advocate’s Corner, a new monthly series to keep you updated on how our Advocate Leaders and policy team are working on behalf of the ovarian and gynecologic cancer community. OCRA’s Advocates are beginning 2024 with great momentum. Here’s a look at our most impactful achievements in 2023: As the largest organization advocating … Continued
[New York, NY January 17, 2024] – Ovarian Cancer Research Alliance (OCRA) proudly announces the successful culmination of an extraordinary year, marking 2023 as a milestone in our pursuit of advancing knowledge, treatment, and support for individuals impacted by ovarian and related gynecologic cancers. Underscoring a testament to the collective commitment to defeating these diseases, … Continued
Dr. Jasmine Plummer of St. Jude Children’s Research Hospital (formerly of Cedars-Sinai Medical Center) is a 2022 recipient of OCRA’s Early Career Investigator Grant. Her OCRA-funded project is focused on better understanding how genetic mutations trigger cancer development. The goal of her research is to find early biomarkers of ovarian cancer and also identify drugs to effectively … Continued
In an interview for the podcast Overlooked, OCRA’s President & CEO Audra Moran talked about the future of ovarian cancer research, and how Ovarian Cancer Research Alliance is harnessing the power of AI to advance discoveries. Read the Overlooked interview with OCRA’s Audra Moran. Listen to the Overlooked podcast episode “Genetics” featuring Sarah DeFeo, OCRA’s … Continued
Dr. Maria Victoria Botuyan of Mayo Clinic Rochester is a 2022 recipient of OCRA’s Early Career Investigator Grant. Her OCRA-funded research is focused on studying how several proteins function together in regulating the repair of DNA, with the aim of using this knowledge to help develop better ovarian cancer therapies over the long term. What … Continued
Many brides count their wedding day as one of the most momentous occasions in their life. And now they have a way to make this milestone even more meaningful long after they have exchanged vows – all thanks to a team of OCRA Heroes who have raised funds for Ovarian Cancer Research Alliance by reselling … Continued
We took meaningful steps in the fight against ovarian and related gynecologic cancers this year, and we couldn’t have done it without your support. Join me for a look at this year’s most important updates, and please stand with us alongside patients, survivors and loved ones, with hope and commitment to a future without ovarian … Continued
Snap Summary: OCRA-funded researchers discovered a potential key to reducing chemotherapy resistance, and reducing recurrence rates for the most common type of ovarian cancer. A research team at Magee-Women’s Research Institute, University of Pittsburgh, made a breakthrough in the fight to tackle chemoresistance, a pervasive issue in ovarian cancer treatment. This groundbreaking study was led … Continued
Snap Summary: New findings could help develop better immune therapy for patients with the most common and lethal subtype of ovarian cancer. A recent study co-authored by Dr. Sherry Wu of The University of Queensland, Brisbane, and made possible in part by funding from OCRA, is making inroads toward immunotherapy as a viable option for … Continued
OCRA’s Fall Advocacy Day Drives Change A sea of teal washed over the Capitol when more than 70 advocates from 30 states met with over 120 Congressional offices to push for legislative initiatives, including Medicare coverage of life-saving tools such as genetic testing, during OCRA’s 2023 Fall Advocacy Day. “Advocacy Day is so important to … Continued
The voices of OCRA’s advocates were amplified by recent television coverage of this year’s Fall Advocacy Day, during which more than 70 people from 30 states met with over 120 Congressional offices to push for critical legislation and funding. Their efforts were broadcast to more than 105,000 viewers, helping to get the message out about the vital … Continued
We are pleased to announce that OCRA’s Chief Program Officer, Sarah DeFeo, has been awarded the inaugural Andrew Godwin Award for Excellence in Community Outreach. Presented by Ovarian Cancer Midwest Focus (OCMF) at University of Minnesota Medical School, the award recognizes DeFeo as an outstanding member in the gynecologic cancer community for her work leading … Continued
Get email updates about research news, action alerts, and ways to join the fight.
